HBM Healthcare Investments AG

HBM Healthcare Investments AG is a Swiss closed-ended investment company dedicated to the global healthcare sector. Its primary purpose is to invest in a diversified portfolio of private and publicly listed companies operating within the fields of biotechnology, human medicine, medical technology, diagnostics, and health IT. With a permanent capital structure, the company holds stakes in growth-stage enterprises, often entering during clinical development phases when products have demonstrated proof of concept. HBM Healthcare Investments AG supports portfolio companies through significant milestones, such as clinical advancements and regulatory approvals, and may increase its positions during initial public offerings or follow-on financings. Its reach is global, focusing on North America, Asia, and Europe, which allows for broad exposure to sector innovations and opportunities. The company’s strategy is underpinned by dedicated private and public equity teams, with a track record of successful exits through trade sales and IPOs. By providing capital and expertise, HBM Healthcare Investments AG plays a key role in advancing new therapies and technologies within the healthcare market, reflecting the sector’s ongoing growth driven by demographic shifts, scientific progress, and global healthcare needs.